Extracorporeal fluid circuit and related methods

Details Extracorporeal fluid circuit and related methods Extracorporeal fluid circuit and related methods

2005-07-05

2005-07-05

Sykes, Angela D. (Department: 3762)

Surgery

Blood drawn and replaced or treated and returned to body

Constituent removed from blood and remainder returned to body

C604S004010, C604S005010, C604S005040, C604S006060, C604S006110, C210S645000, C210S646000

Reexamination Certificate

active

06913588

ABSTRACT:
A circuit for extracorporeal treatment of a body fluid, the circuit including in serial fluidic communication an inlet for receiving the body fluid from a patient, a first pump, a first treatment device for processing the body fluid, a second pump, an outlet for returning processed body fluid to the patient; and a shunt. The shunt is upstream from the first pump and downstream from the second pump.

REFERENCES:
patent: 4209391 (1980-06-01), Lipps et al.
patent: RE30724 (1981-08-01), Klayum et al.
patent: 4435127 (1984-03-01), Kränzle et al.
patent: 4500309 (1985-02-01), Diederich et al.
patent: 4540399 (1985-09-01), Litzie et al.
patent: 4618343 (1986-10-01), Polaschegg et al.
patent: 4658655 (1987-04-01), Kanno
patent: 4828543 (1989-05-01), Weiss et al.
patent: 4844810 (1989-07-01), Richalley et al.
patent: 4855057 (1989-08-01), Ohnishi et al.
patent: 4863590 (1989-09-01), Ohnishi et al.
patent: 4897184 (1990-01-01), Shouldice et al.
patent: 4925555 (1990-05-01), Spielberg
patent: 4950225 (1990-08-01), Davidner et al.
patent: 5062442 (1991-11-01), Stenstrom et al.
patent: 5069662 (1991-12-01), Bodden
patent: 5368555 (1994-11-01), Sussman et al.
patent: 5411479 (1995-05-01), Bodden
patent: 5429938 (1995-07-01), Humes
patent: 5470483 (1995-11-01), Bene et al.
patent: 5476444 (1995-12-01), Keeling et al.
patent: 5549674 (1996-08-01), Humes et al.
patent: 5630946 (1997-05-01), Hart et al.
patent: 5647984 (1997-07-01), Hovland et al.
patent: 5686289 (1997-11-01), Humes et al.
patent: 5690831 (1997-11-01), Kenley et al.
patent: 5725492 (1998-03-01), Igo et al.
patent: 5776091 (1998-07-01), Brugger et al.
patent: 5813842 (1998-09-01), Tamari
patent: 5814004 (1998-09-01), Tamari
patent: 5817046 (1998-10-01), Glickman
patent: 6060270 (2000-05-01), Humes
patent: 6150164 (2000-11-01), Humes
patent: 6561997 (2003-05-01), Weitzel et al.
patent: 0 490 212 (1992-06-01), None
patent: 0 796 997 (1997-09-01), None
patent: 2 686 255 (1993-07-01), None
patent: 2 702 962 (1994-09-01), None
patent: WO 00/64510 (2000-09-01), None
Ahmad et al. (1988), “Center and Home Chronic Hemodialysis” inDisease of the Kidney(Schrier RW and Goffschalk CW eds.), 4thEd., Boston: Little, Brown and Co., 3281-3319, 3322-3329, 3332-3343.
Avissar et al. (Feb. 1994), “Human Kidney Proximal Tubules are the Main Source of Plasma Glutahione Peroxidase,”American Journal of Physiology, 266(2):C367-C375.
Bacallao et al. (1989), “Molecular events in the Organization of Renal Tubular Epithelium: from Nephrogenesis to Regeneration,”American Physiological Society, 257:F913-F924.
Bäckman et al. (1988), “Glutahione Transferase in the Urine: A Market for Post-Transplant Tubular Lesions,”Kidney Int'l.,33:571-577.
Beutler (ed.) (1984), “Glutathione Peroxidase (GSH-Px),” inRed Cell Metabolism: A Manual of Biochemical Methods, 3rdEdition, Grune & Stratton, New York, pp. 74-76.
Bhalla (1989), “Hormones and the Immune Response,”Annals of the Rheumatic Diseases, 48(1):1-6.
Bikle et al. (1992), “Clinical Counterpoint: Vitamin D: New Actions, New Analogs, New Therapeutic Potential,”Endocrine Reviews, 13(4):765-784.
Calne (Dec. 1970), “Organ Transplantation Between Widely Disparate Species,”Transplantation Proceedings, 2(4):550-556.
Cieslinski (Aug. 1, 1995), “Excerpt from Phase I Grant Application entitled, ‘Tissue Engineering of a Biohybrid Human Kidney Tubule,’”Small Business Program Phase I Grant Application, No. SBIR 94-3, pp. 1-2, 4, 10-24.
Cieslinski (Aug. 1, 1996), “Excerpt from Phase II Grant Application entitled, ‘Bioartificial Renal Tubule for Renal Failure Therapy,’”Small Business Program Phase II Grant Application, Solicitation No. DK-50539, pp. 1, 13-40.
Cieslinski et al. (Mar. 25, 1994), “Tissue Engineering of a Bioartificial Kidney,”Biotechnology and Bioengineering, 43(7):678-681.
Cooper et al. (1991), “The Pig as Potential Organ Donor for Man,” inXeno-Transplantation(Cooper et al. eds.), Springer, Berlin, Chapter 30, pp. 481-500.
Cozzi et al. (Sep. 1995), “The Generation of Transgenic Pigs as Potential Organ Donors for Humans,”Nature Medicine, 1(9):964-966.
Curthoys (1983), “Role of γ-Glutamyltranspeptidase in the Renal Metabolism of Glutathione,”Mineral and Electrolyte Metabolism, 9:236-245.
Deneke et al. (Oct. 1989), “Regulation of Cellular Glutahione,”American Journal of Physiology, 257(4):L163-L173.
Dröge et al. (Nov. 1994), “Functions of Glutathione and Glutathione Disulfide in Immunology and Immunopathology,”The FASEB Journal, 8(14):1131-1138.
Fleck (1992), “Renal Transport of Endogenous Amino Acids,”Renal Physiol Biochem, 15:257-276.
Fonteles et al. (1976), “Extraction of Glutathione by the Isolated Perfused Rabbit Kidney,”Journal of Surgical Research, 21:169-174.
Frank et al. (1993), “Human Renal Tubular Cells as Cytokine Source: PDGF-B, GM-CSF and IL-6 mRNA Expression In Vitro,”Exp Nephrol, 1:26-35.
Galley et al. (1996), “The Immuno-Inflammatory Cascade”,British Journal of Anasethesia, 77:11-16.
Gillin et al. (1993), “Urea Transport in the Kidney,”Seminars in Nephrology, 13(2):146-154.
Goode et al. (1993), “Free Radicals and Antioxidants in Sepsis”,Critical Care Medicine, 21(11):1770-1776.
Hall et al. (1989), “Stem Cells: The Generation and Maintenance of Cellular Diversity,”Development, 106:619-633.
Hammerman et al. (1993), “The Growth Hormone Insulin-Like Growth Factor Axis in Kidney Revisited,”American Physiological Society, 265:F1-F14.
Howard et al. (Apr. 1993), “Interleukin 10 Protects Mice From Lethal Endotoxemia.”J. Exp. Med.,177(4):1205-1208.
Humes (1995), Abstract of “Cell Therapy for Erythropoietin (EPO) Deficient Anemias,”Dialysis: Complications/Outcomes, J.A.S.N. 6:535.
Humes (1995), “Tissue Engineering of the Kidney,” inThe Biomedical Engineering Handbook, (Joseph D. Bronzino ed.-in-chief), CRC Press, Boca Raton, Chapter 121, 1807-1824.
Humes (1995), Abstract of “Tissue Engineering of a Bioartificial Hemofilter,”Dialysis: Access/Methods of Hemodialysis, J.A.S.N. 6:492.
Humes (Aug. 1996), “Tissue Engineering of a Bioartificial Kidney: A Universal Donor Organ,”Transplantation Proceedings, 28(4):2032-2035.
Humes et al. (1995), Abstract of “Tissue Engineering of a Bioartificial Renal Tubule,”J.A.S.N.,6(3):465.
Humes (1995), Abstract of “Tissue Engineering of a Biohybrid Kidney Filter and Kidney Tubule,”Journal of Cellular Biochemistry, Abstract Supplement 0(21B):9.
Humes (1997), “Application of Cell and Gene Therapies in the Tissue Engineering of Renal Replacement Devices,” inPrinciples of Tissue Engineering(Lanza et al. eds.), R.G. Landes Company, Austin Texas, Chapter 35, 577-589.
Humes (1996), “The Bioartificial Renal Tubule: Prospects to Improve Supportive Care in Acute Renal Failure,”Renal Failure, 18(3):405-408.
Humes (1995), “Acute Renal Failure: Prevailing Challenges and Prospects for the Future,”Kidney International, 48, Suppl. 50:S-26—S-32.
Humes et al. (Feb. 1995), “Prospects for an Implantable Bioartificial Kidney,”Contemporary Dialysis&Nephrology, 16(2):24-27.
Humes et al. (Jul. 1996), “Tubulogenesis From Isolated Single Cells of Adult Mammalian Kidney: Clonal Analysis with a Recombinant Retrovirus,”American Journal of Physiology, 271(1):F42-F49.
Humes et al. (Jul. 1992), “Interaction Between Growth Factors and Retinoic Acid in the Induction of Kidney Tubulogenesis in Tissue Culture,”Experimental Cell Research, 201(1):8-15.
Humes et al. (1980), “Ionophore A23187 Induced Reductions in Toad Urinary Bladder Epithelial Cell Oxidative Phosphorylation and Viability,”Pflügers Arch.,388:217-220.
Humes et al. (Ma

Affiliated with

Also associated with

Rating

Extracorporeal fluid circuit and related methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Extracorporeal fluid circuit and related methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extracorporeal fluid circuit and related methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3385808